UQCCR Seminar Series with Dr Andreas Obermair and Shawn Carlson

Decades of Discovery: The Evolution of QCGC Research’s Clinical Trials with Professor Andreas Obermair
Professor Andreas Obermair is a RANZCOG-accredited Gynaecological Oncologist. He is a Professor at the University of Queensland's Centre for Clinical Research and leads the Queensland Centre for Gynaecological Cancer (QCGC) Research. In addition to operating a private practice, Prof. Obermair holds a staff specialist position at the Royal Brisbane and Women’s Hospital. Prof. Obermair is a prominent figure in Gynaecological Oncology research, having led pivotal trials such as LACC and LACE, and continues to spearhead ongoing studies like ENDO-3, ANVU, pre-ANVU, FeMMe, and SATELLITE. Over the years, he has transformed the way trials are developed at QCGC Research, emphasising translational studies, cross-institute collaboration, and industry partnerships. He also co-founded the Cherish Women's Cancer Foundation, which supports research into more effective and compassionate treatments for gynaecological cancers.  

Spatial Multiomics – Broadening the capabilities of Imaging Mass Spectrometry with Shawn Carlson, Scientist at Ambergen
Overview: MALDI HiPLEX-IHC is a breakthrough, affordable technology combining the techniques of Immunohistochemistry (IHC) and Imaging mass spec - using existing infrastructure to enable the imaging of intact proteins in tissue samples. 

• Ultra high-plex: allowing 100 or more protein biomarkers to be analysed simultaneously without cycling of any kind. 
• Multi-Omic: Image metabolite and lipid distributions, small molecule drugs, intact proteins, glycans, and now even RNA, all on the same sample on the same imaging instrument. 
• Non-destructive: Since the tissue is not destroyed, it is multimodal-friendly allowing other spatial biology imaging modalities to be used either before or after. 

Morning tea wil be provided by Ambergen after the seminar. Please register for catering purposes.